LADENBURG THALMANN FINANCIAL SERVICES INC. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 87 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$1,0000.0%500.0%0.00%
Q4 2018$1,000
-92.9%
50
-91.8%
0.00%
Q3 2018$14,000
-30.0%
609
-46.3%
0.00%
Q3 2017$20,000
+122.2%
1,134
+116.0%
0.00%
Q2 2017$9,000
-96.9%
525
-97.4%
0.00%
-100.0%
Q1 2017$287,000
-10.9%
20,525
+1.7%
0.00%0.0%
Q4 2016$322,000
-3.3%
20,191
+1.0%
0.00%
-20.0%
Q3 2016$333,000
+48.7%
20,0000.0%0.01%
+25.0%
Q2 2016$224,000
+34.1%
20,0000.0%0.00%
+33.3%
Q1 2016$167,000
-10.2%
20,0000.0%0.00%0.0%
Q4 2015$186,000
-17.7%
20,0000.0%0.00%
-40.0%
Q3 2015$226,000
-37.7%
20,000
-30.1%
0.01%
-28.6%
Q2 2015$363,000
+36.5%
28,6000.0%0.01%
+40.0%
Q1 2015$266,000
-36.4%
28,600
-2.0%
0.01%
-44.4%
Q4 2014$418,000
+38.0%
29,1750.0%0.01%
+12.5%
Q3 2014$303,000
-35.8%
29,1750.0%0.01%
-38.5%
Q2 2014$472,000
-0.4%
29,1750.0%0.01%
-7.1%
Q1 2014$474,000
+27.4%
29,175
-2.8%
0.01%
+27.3%
Q4 2013$372,000
+7.8%
30,000
-4.8%
0.01%
-8.3%
Q3 2013$345,000
+42.6%
31,500
+5.0%
0.01%
+33.3%
Q2 2013$242,00030,0000.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders